therapy
A mini-pharmacoeconomic       analysis based on claims data over a 6-month period from HMO Colorado, a health       maintenance organization, shows that switching patients on dual therapy with a       calcium channel blocker and an ACE inhibitor to 1-pill combination therapy with       both agents can result in substantial cost savings.
A mini-pharmacoeconomic       analysis based on claims data over a 6-month period from HMO Colorado, a health       maintenance organization, shows that switching patients on dual  @SUBJECT$   @PREDICAT$  a        @OBJECT$  and an ACE inhibitor to 1-pill combination therapy with       both agents can result in substantial cost savings.